Changes in relative cerebral blood volume 1 month after radiation-temozolomide therapy can help predict overall survival in patients with glioblastoma.

• To evaluate perfusion parameter changes in patients with glioblastoma multiforme by comparing the perfusion magnetic resonance (MR) imaging measurements obtained before combined radiation and temozolomide therapy (RT-TMZ) with the follow-up MR imaging measurements obtained 1 month after completion of this treatment.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Nyckelord

Adult

Aged

Aged

80 and over

Antineoplastic Agents

Alkylating

therapeutic use

Blood Volume

Brain Neoplasms

diagnosis

mortality

therapy

Dacarbazine

analogs & derivatives

therapeutic use

Female

Glioblastoma

diagnosis

mortality

therapy

Humans

Incidence

Magnetic Resonance Imaging

statistics & numerical data

Male

Middle Aged

Radiotherapy

Conformal

mortality

Survival Analysis

Survival Rate

Treatment Outcome

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)